500
Participants
Start Date
January 31, 2013
Primary Completion Date
December 31, 2018
Study Completion Date
February 28, 2023
Sentinel lymph node biopsy followed by axillary lymph node dissection
This is a retrospective study to determine the feasibility of sentinel lymph node biopsy (SLNB) after neoadjuvant systemic therapy (NAST) according to response to NAST and breast cancer subtypes. All patients received SLNB followed by axillary lymph node dissection after NAST.
Gangnam Severance Hospital
OTHER